Dr. Cerhan's Lymphoma Epidemiology Lab at Mayo Clinic receives funding from the National Institutes of Health (NIH) and the Lymphoma Research Foundation. Funding helps support the lab's research on the genetic epidemiology of lymphoma, lymphoma outcomes epidemiology, population-based cancer epidemiology and more.

Review Dr. Cerhan's grant information.

Some of our recent funding includes:

Investigator & Role Grant Title Funding Source Duration
James R. Cerhan, M.D., Ph.D., co-principal investigator with Mayo Clinic collaborator Anne J. Novak, Ph.D. Genetic Predictors of Early Clinical Failure in DLBCL (R01 CA212162) National Cancer Institute 08/01/2017-07/30/2022
James R. Cerhan, M.D., Ph.D., co-leader with Mayo Clinic collaborators Anne J. Novak, Ph.D., and Lisa M. Rimsza, M.D., and external collaborator Brian K. Link, M.D. Genomic Predictors of Early Relapse in Immunochemotherapy-Treated Follicular Lymphoma (P50 CA97274 — Project 4 of Lymphoma Specialized Program of Research Excellence) National Cancer Institute 07/01/2017-06/30/2022
James R. Cerhan, M.D., Ph.D., principal investigator Genetic Epidemiology of Non-Hodgkin's Lymphoma (R01 CA200703) National Cancer Institute 07/08/2016-5/31/2021
James R. Cerhan, M.D., Ph.D., principal investigator with external collaborator Christopher R. Flowers, M.D. The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (U01 CA195568) National Cancer Institute 6/23/2015-5/31/2020
James R. Cerhan, M.D., Ph.D., co-investigator with Mayo Clinic collaborator S. Vincent Rajkumar, M.D., principal investigator Prevalence and Progression of Monoclonal Gammopathies (R01 CA107476) National Cancer Institute 04/08/2014-02/28/2019
James R. Cerhan, M.D., Ph.D., principal investigator of subcontract with external collaborator Charles Lynch, M.D., Ph.D., principal investigator Iowa Population-Based Cancer Epidemiology Research Center: Consortium U. Iowa (N01 PC35143) National Cancer Institute 07/01/2012-04/30/2018